Corcept Therapeutics (CORT) Current Assets (2010 - 2026)
Corcept Therapeutics (CORT) posted Current Assets of $439.7 million for Q2 2026, up 3.2% sequentially from $426.0 million in Q1 2026, and down 0.78% YoY from $443.1 million in Q2 2025.
Corcept Therapeutics (CORT) Current Assets (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Current Assets for 17 years, with the latest figure at $439.7 million in Q2 2026.
- Quarterly Current Assets fell 0.78% year-over-year to $439.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $439.7 million (down 0.78% YoY) and the FY2025 annual result came in at $485.5 million, up 2.94% from the prior year.
- Current Assets grew to $439.7 million in Q2 2026 per CORT's latest filing, from $426.0 million in the prior quarter.
- Over five years, Current Assets peaked at $560.8 million in Q2 2024 and troughed at $388.2 million in Q1 2022.
- A 5-year average of $466.2 million and a median of $455.5 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets jumped 87.36% in 2022, then slipped 20.99% in 2025.
- Over 5 years, Current Assets stood at $499.3 million in 2022, then retreated by 8.14% to $458.6 million in 2023, then climbed by 2.83% to $471.6 million in 2024, then gained by 2.94% to $485.5 million in 2025, then decreased by 9.43% to $439.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $439.7 million, $426.0 million, and $485.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 439.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 439.68 Mn |
| Mar 31, 2026 | 426.03 Mn |
| Dec 31, 2025 | 485.46 Mn |
| Sep 30, 2025 | 541.13 Mn |
| Jun 30, 2025 | 443.11 Mn |
| Mar 31, 2025 | 438.50 Mn |
| Dec 31, 2024 | 471.60 Mn |
| Sep 30, 2024 | 466.98 Mn |
| Jun 30, 2024 | 560.85 Mn |
| Mar 31, 2024 | 503.37 Mn |
| Dec 31, 2023 | 458.64 Mn |
| Sep 30, 2023 | 431.53 Mn |
| Jun 30, 2023 | 432.59 Mn |
| Mar 31, 2023 | 533.89 Mn |
| Dec 31, 2022 | 499.25 Mn |
| Sep 30, 2022 | 452.40 Mn |
| Jun 30, 2022 | 419.05 Mn |
| Mar 31, 2022 | 388.22 Mn |
| Dec 31, 2021 | 266.46 Mn |
| Sep 30, 2021 | 401.90 Mn |